Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01805895 · ClinicalTrials.gov registry record · Phase 1
A Pilot Study of Minocycline in Intracerebral Hemorrhage Patients
A Phase 1 study, sponsored by Augusta University.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT01805895 is a Phase 1 study that has completed, run by Augusta University. The registered enrollment target is 16 participants.
The verdict
NCT01805895, a Phase 1 study, has completed, sponsored by Augusta University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
The MACH Trial is a pilot study of 400mg minocycline over five days in acute intracerebral hemorrhage patients. The study will evaluation the safety and efficacy of minocycline in intracerebral hemorrhage patients.
Interventions
- DRUG Minocycline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2013-02 |
| Est. Completion | 2016-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01805895
The ClinicalTrials.gov registry entry for NCT01805895 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Augusta University, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Minocycline is the first listed.
NCT01805895 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01805895 about?
NCT01805895 is a clinical study titled "A Pilot Study of Minocycline in Intracerebral Hemorrhage Patients". The MACH Trial is a pilot study of 400mg minocycline over five days in acute intracerebral hemorrhage patients. The study will evaluation the safety and efficacy of minocycline in intracerebral hemorrhage patients.
What is the current status of trial NCT01805895?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2013-02. Estimated completion is 2016-12.
What interventions are being tested in trial NCT01805895?
The interventions under investigation include: Minocycline (DRUG).
Who is sponsoring clinical trial NCT01805895?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.